THU, 22 OCT 2026|
[BRAND]
LATEST
01THE INTERVIEW: Stephen Symons’ Starlorn finds fragile humanity amid the fractures of war02Giannis says new-look Heat 'got to trust each other more' after blowout loss03Self says KU fans crossed line aiming profanity at ex-Jayhawks star Bidunga04Government websites go dark after AI-discovered flaw sparks security scramble05U.S. pulls diplomats from Saudi Arabia as it reportedly readies Iran strikes after midterms06What Kim Yo-jong’s border warnings reveal about inter-Korean escalation risk07Could China’s 100-channel single-photon detector enable broadband quantum internet?08Out-of-home care manager pleads not guilty to choking, raping colleagues
Feed/General
General

Health ministry questions reliability of vasculitis drug approval data

The Japan Times
Published 22 Oct 2026, 2:40 pm·1 h ago·1 min read
Listen to this story
Read aloud by your device

Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Read the full story at The Japan Times
japantimes.co.jp
Open ↗

Related

General

Government websites go dark after AI-discovered flaw sparks security scramble

just now·Daily Maverick·1 min read
General

North Korea’s Kim Yo Jong warns South Korea, says border loudspeakers to be ready

just now·Daily Maverick·1 min read
General

New World screwworm cases confirmed in wildlife in Texas, beef cow in New Mexico

1 min ago·Daily Maverick·1 min read
General

Could China’s 100-channel single-photon detector enable broadband quantum internet?

20 min ago·South China Morning Post·1 min read
General

Out-of-home care manager pleads not guilty to choking, raping colleagues

23 min ago·ABC News (AU)·1 min read